Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma

Jonathan L. Berkowitz, John E. Janik, Donn M. Stewart, Elaine S. Jaffe, Maryalice Stetler-Stevenson, Joanna H. Shih, Thomas A. Fleisher, Maria Turner, Nicole E. Urquhart, Gilian H. Wharfe, William D. Figg, Cody J. Peer, Carolyn K. Goldman, Thomas A. Waldmann*, John C. Morris

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences